US Federal 2025-2026 Regular Session

US Federal Senate Bill SB2426

Introduced
7/24/25  

Caption

Equitable Community Access to Pharmacist Services Act

Impact

The primary impact of SB2426 on state laws revolves around the acknowledgment of pharmacists as healthcare providers. This is a pivotal change as it aligns the reimbursement mechanisms for pharmacists with those currently available for physicians, which may incentivize pharmacists to expand their roles in patient care. The bill also specifies that services must be conducted under the supervision of a physician when required by state law, reinforcing the collaborative nature of modern healthcare delivery systems. This shift is expected to enhance community access to crucial health services, particularly in underserved areas.

Summary

SB2426, titled the 'Equitable Community Access to Pharmacist Services Act', introduces significant amendments to the Social Security Act, specifically targeting the coverage and payment of pharmacist services under Medicare Part B. The bill aims to ensure that services offered by licensed pharmacists are recognized within Medicare, expanding the scope of healthcare delivery. By formally including 'pharmacist services' as eligible for reimbursement, the legislation positions pharmacists as vital healthcare providers in the management and treatment of various health conditions, such as COVID-19 and other respiratory ailments.

Contention

However, the bill has not been without contention. Critics may raise concerns regarding the qualifications and oversight of pharmacists performing medical services typically reserved for medical doctors, especially in instances where complex health issues arise. There may also be debates regarding the financial implications of increased reimbursements for pharmacist services, particularly how these changes will affect Medicare spending. Furthermore, as the bill prohibits balance billing for these services, stakeholders will need to address the implications for pharmacists’ compensation and the sustainability of service provision within the constraints of Medicare reimbursement policies.

Companion Bills

US HB3164

Related Ensuring Community Access to Pharmacist Services Act

Previously Filed As

US HB3164

Ensuring Community Access to Pharmacist Services Act

US HB7189

PrEP Access Act

US SB3607

Access to Genetic Counselor Services Act of 2026

US HR805

Recognizing October 2025 as "American Pharmacists Month" in honor of the contribution of pharmacists to provide safe, accessible, affordable, and beneficial patient care services and products to all residents and protect the public health of our communities.

US SB324

Relating To Pharmacists.

US SB324

Relating To Pharmacists.

US SB1245

Relating To Pharmacists.

US HB6280

Access to Genetic Counselor Services Act of 2025

US SB1579

Relating To Pharmacists.

US SB1579

Relating To Pharmacists.

Similar Bills

NJ A3359

Regulates provision of pharmaceutical services in nursing homes.

NJ S2990

Regulates provision of pharmaceutical services in long-term care facilities.

CA AB1366

Reimbursement for pharmacist services.

CA AB2571

Reimbursement for pharmacist services.

HI SB1245

Relating To Pharmacists.

MD SB562

State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

MD HB838

State Board of Pharmacy - Prescriber-Pharmacist Agreements

TX HB3540

Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.